Asset
MECASERMIN
Eton Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| BLA 021839 | BLA | Eton Pharmaceuticals, Inc. |
Marketed products (1)
- INCRELEX